Back

UroGen Pharma Quote, Financials, Valuation and Earnings

Buy

URGN
UroGen Pharma

Last Price:

12.93

Seasonality Move:

13.95%

7 Day Trial

ALL ACCESS PASS

$ 7

UroGen Pharma Price Quote

$12.93

-0.29 (-2.19%)

(Updated: May 20, 2024 at 6:55 PM ET)

UroGen Pharma Key Stats

Buy

UroGen Pharma (URGN) is a Buy

Day range:

$12.84 - $13.46

52-week range:

$8.69 - $24.13

Dividend yield:

P/E ratio:

0.00

P/S ratio:

4.92

P/B ratio:

Volume:

232K

Avg. volume:

323K

1-year change:

11.09%

Market cap:

$477.6M

Revenue:

$82.7M

EPS:

$-3.34

How Much Does UroGen Pharma Make?

How Much Are UroGen Pharma's Sales Annually?
URGN Revenues are $82.7M
How Much Profit Does UroGen Pharma's Make A Year?
URGN net income is -$102.2M

Is UroGen Pharma Growing As A Company?

What Is UroGen Pharma's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.09%
What Is UroGen Pharma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%

UroGen Pharma Stock Price Performance

Did UroGen Pharma Stock Go Up Last Month?
UroGen Pharma share price went down by -7.16% last month
Did URGN's Share Price Rise Over The Last Year?
URGN share price rose by 11.09% over the past 1 year

What Is UroGen Pharma 52-Week High & Low?

What Is UroGen Pharma’s 52-Week High Share Price?
UroGen Pharma has traded as high as $24.13 over the past 52 weeks
What Is UroGen Pharma’s 52-Week Low Share Price?
UroGen Pharma has traded as low as $8.69 over the past 52 weeks

UroGen Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy UroGen Pharma?

How Much Debt Does UroGen Pharma Have?
Total long term debt quarterly is $97.6M
How Much Cash Does UroGen Pharma Have?
Cash and short term investments quarterly total is $164M
What Is UroGen Pharma’s Book Value Per Share?
Book value per share is -1.11

Is UroGen Pharma Cash Flow Positive?

What Is URGN Cash Flow From Operations?
Cash flow from operations (TTM) is -$82.3M
What Is UroGen Pharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is $170.9M
What Is UroGen Pharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is $6.3M

UroGen Pharma Return On Invested Capital

Is Management Doing A Good Job?
URGN return on invested capital is -588.9%
What Is UroGen Pharma Return On Assets?
ROA measures how assets are converting to revenues and is -66.8%
What Is URGN Return On Equity?
ROE is a measure of profitability and is 0%

UroGen Pharma Earnings Date & Stock Price

What Is UroGen Pharma's Stock Price Today?
A single share of URGN can be purchased today for 13.22
What Is UroGen Pharma’s Stock Symbol?
UroGen Pharma trades on the nasdaq under the ticker symbol: URGN
When Is UroGen Pharma’s Next Earnings Date?
The next quarterly earnings date for UroGen Pharma is scheduled on May 21, 2024
When Is URGN's next ex-dividend date?
UroGen Pharma's next ex-dividend date is May 21, 2024
How To Buy UroGen Pharma Stock?
You can buy UroGen Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

UroGen Pharma Competitors

Who Are UroGen Pharma's Competitors?
Below is a list of companies who compete with UroGen Pharma or are related in some way:
- Agenus Inc (AGEN)
- Exelixis Inc (EXEL)
- Geron Corp (GERN)
- InfuSystems Holdings Inc (INFU)
- Protalix BioTherapeutics Inc (PLX)

UroGen Pharma Dividend Yield